A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced a strategic ...

Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...

CRO" running radically faster, more reliable clinical trials for life sciences, has announced the appointment of distinguished diagnostic and genomic medicine pioneer Dr. Paul Billings to its ...

Inovor Technologies is blending sovereign design with global partnerships to redefine Australia’s satellite manufacturing ...

Investing.com -- Exelixis Inc (NASDAQ:EXEL) stock rose 3.8% and Natera Inc (NASDAQ:NTRA) shares gained 1.6% Wednesday after the companies announced a collaboration on a pivotal phase 3 trial for ...

Impact Minerals weighs membrane tech to accelerate Lake Hope HPA, aiming for lower capex/opex, water savings and new ...